NCT00003882View on ClinicalTrials.gov

Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

April 30, 2000

Study Completion Date

September 30, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

anhydrovinblastine

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00003882 - Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors | Biotech Hunter | Biotech Hunter